Jefferies Starts Apollo Medical Holdings (AMEH) at Buy, 'unique model'

Go back to Jefferies Starts Apollo Medical Holdings (AMEH) at Buy, 'unique model'

BofA Securities Upgrades Apollo Medical Holdings (AMEH) to Buy, 'embedded earnings begin to show up in results'

February 22, 2024 8:18 AM EST

(Updated - February 22, 2024 9:28 AM EST)

BofA Securities analyst Adam Ron upgraded Apollo Medical Holdings (NASDAQ: AMEH) from Neutral to Buy with a price target of $55.00 (from $44.00).

The analyst comments "Company set to double revenue over next couple of years through... More

Apollo Medical Holdings (AMEH) Rebrands as Astrana Health, Changes Ticker to ASTH

February 22, 2024 8:04 AM EST

Apollo Medical Holdings, Inc.("ApolloMed," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: AMEH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all, announced today it will formally change its name from... More